FDBusiness.com

Extended use of Glavonoid™

 Breaking News
  • Bel to Produce Mini Babybel at its First Canadian Factory Bel Group, a world leader in branded cheese and a major player in the healthy snack market, plans to build its first Canadian plant in Sorel-Tracy, Quebec. The facility, which is scheduled to begin commercial production in early 2020, will be fully dedicated to producing Mini Babybel® cheese. These dairy snacks encased in small and [...]...
  • Irish Whiskey Industry Welcomes EU-Japan Trade Agreement The Irish Whiskey Association has welcomed the signing of the EU-Japan Economic Partnership Agreement, the largest trade deal negotiated yet by the European Union. While sales of Irish whiskey remain relatively low, Japan is currently the largest market in Asia for Irish whiskey and last year Irish whiskey sales in Japan recorded a 15.7% growth to [...]...
  • Optimal Packaging – iba.OPERATE! Sustainable, efficient, safe, fast and smart: With “iba.OPERATE! Packaging & Processing Solutions”, iba is dedicating a large special section in hall B1 to packaging solutions, materials and processes. An attractive appearance is not everything. Hygienic packaging is just as crucial, especially in the food sector. Over 180 companies will be presenting their solutions and novelties in [...]...
  • Eriez Magnetics Europe Celebrates 50 Years of Manufacturing Excellence Industry-leading manufacturers, Eriez Magnetics Europe Ltd, mark its 50th anniversary this year. From humble beginnings has emerged a company who now has a strong customer base and can proudly boast numerous technological achievements and significant growth over half a century. Eriez Europe was established when Bob Merwin, CEO of Eriez Manufacturing Co. in Erie, USA recognised [...]...
  • Royal Unibrew Completes Acquisition of French Lemonade Business Royal Unibrew, the Denmark-based beverages group, has completed the acquisition of Etablissements Geyer Fréres for an enterprise value of DKr660 million (€88.5 million) financed by bank debt. The acquisition of Etablissements Geyer Fréres will give Royal Unibrew increased access to the French soft drinks market and will further strengthen its export portfolio. Employing about 100 [...]...

Extended use of Glavonoid™

Extended use of Glavonoid™
September 08
15:56 2015

Further approved fields of application enable new products to be launched

 Brussels (Belgium), September 2015Kaneka Pharma Europe, developer and patent holder of the liquorice root extract Glavonoid™, has successfully secured extended use approval for the novel food ingredient from the European Commission. Glavonoid™ offers unique support in reducing visceral fat. Besides being used in food supplements and beverages based on milk, yoghurt, fruit and vegetables, as accredited by its Novel Food status since 2011, Glavonoid can now also be applied in foods intended for medical purposes and energy-restricted diets for weight reduction.  

In DNA microarray analysis, Glavonoid™ has been shown to exhibit a two-way efficiency mechanism: On the one hand, it increases the body’s own fat burning ability by up-regulating genes involved in fatty acid oxidation, and on the other, it decreases fat development by down-regulating genes that are involved in fatty acid synthesis. Besides lowering body weight and BMI (body mass index), Glavonoid™ may also optimize cholesterol and blood glucose levels[1]. Derived from liquorice root (Glycyrrhiza glabra L.) via an advanced patented process, Glavonoid™ is 100 per cent free from glycyrrhizinic acid and contains 30 per cent liquorice glabra polyphenols. The allowed daily dose is 120 mg for adults.

Peter Lambrechts, Business Development Manager at Kaneka’s Quality of Life Division, who successfully guided the approval process, states: “With visceral fat being the main risk factor for the development of metabolic syndromes and other chronic diseases such as cardiovascular illnesses, we see extremely promising market potential here. The new regulatory status for Glavonoid™ paves the way for manufacturers to create new products targeting markets such as weight management and body shaping.

Glavonoid™ can be used in supplements as a single ingredient or as part of a multi-component system. It can also be included in products aimed at the sports and fitness market, as well as healthy ageing.

[1]Tominaga, Y. et al.: Obesity Research & Clinical Practice (2009) 3, 169-178

About Author

admin

admin

Related Articles



Food & Drink Business Conference & Exhibition 2016

Upcoming Events

  • September 5, 2018Int'l Food Products and Processing Technologies Exhibition (WorldFood Istanbul)
  • September 15, 2018iba
  • September 25, 2018PPMA Show 2018
  • September 27, 2018Int'l Fruit Show (eurofruit)
AEC v1.0.4

find food jobs

The Magazine

F&D Business Preferred Suppliers

New Subscriber





Subscribe Here



Advertisements